Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-AKT2 Antibody (R3J20)

Catalog #:   RHD96601 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2b
Applications: IF, IHC, WB
Accession: P31751
Overview

Catalog No.

RHD96601

Species reactivity

Human, Rat, Monkey

Host species

Mouse

Isotype

IgG2b

Clonality

Monoclonal

Tested applications

IF: 1:200-1:1000, IHC: 1:200-1:1000, WB: 1:500-1:2000

Target

PKB beta, Protein kinase Akt-2, AKT2, Protein kinase B beta, RAC-beta serine/threonine-protein kinase, RAC-PK-beta

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P31751

Applications

IF, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3J20

Data Image
  • Immunofluorescence
    Immunofluorescence analysis of PANC-1 (left) and Hela (right) cells using AKT2 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.
  • Immunohistochemical
    Immunohistochemical analysis of paraffin-embedded human Thymus tissues using anti-AKT2 mAb
  • Western blot
    Western blot analysis using AKT2 mouse mAb against A431 (1), Jurkat (2), HEK293 (3), A549 (4), MCF-7 (5) and PC-12 (6) cell lysate.
References

Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group., PMID:38894867

Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells., PMID:38636680

K-Ras(V12) differentially affects the three Akt isoforms in lung and pancreatic carcinoma cells and upregulates E-cadherin and NCAM via Akt3., PMID:38291468

Nogo-B deficiency suppresses white adipogenesis by regulating β-catenin signaling., PMID:36931495

Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer., PMID:36930815

Akt1-dependent expression of angiopoietin 1 and 2 in vascular smooth muscle cells leads to vascular stabilization., PMID:35931736

Analysis of rs1864182 and rs1864183 variants in ATG10 gene and antineutrophil cytoplasmic autoantibody-associated vasculitis in Chinese Guangxi population., PMID:34961976

Blockade of macrophage-associated programmed death 1 inhibits the pyroptosis signalling pathway in sepsis., PMID:34382103

Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation., PMID:33707617

Ultrasound molecular imaging-guided tumor gene therapy through dual-targeted cationic microbubbles., PMID:33594996

Isoform- and Phosphorylation-specific Multiplexed Quantitative Pharmacodynamics of Drugs Targeting PI3K and MAPK Signaling in Xenograft Models and Clinical Biopsies., PMID:33536190

The endocannabinoid 2-arachidonoylglycerol and dual ABHD6/MAGL enzyme inhibitors display neuroprotective and anti-inflammatory actions in the in vivo retinal model of AMPA excitotoxicity., PMID:33450278

An AKT2-specific nanobody that targets the hydrophobic motif induces cell cycle arrest, autophagy and loss of focal adhesions in MDA-MB-231 cells., PMID:33378961

Semaphorin 4A antibody alleviates arsenic-induced hepatotoxicity in mice via inhibition of AKT2/NF-κB inflammatory signaling., PMID:33290778

Akt isoform-specific effects on thyroid cancer development and progression in a murine thyroid cancer model., PMID:33110146

Development and characterization of protein kinase B/AKT isoform-specific nanobodies., PMID:33045011

AKT2 deficiency impairs formation of the BCR signalosome., PMID:32252758

The AKT isoforms 1 and 2 drive B cell fate decisions during the germinal center response., PMID:31767615

CXCL13 is a differentiation- and hypoxia-induced adipocytokine that exacerbates the inflammatory phenotype of adipocytes through PHLPP1 induction., PMID:31710352

Protein kinase Akt2/PKBβ is involved in blastomere proliferation of preimplantation mouse embryos., PMID:31552693

Neutrophils homing into the retina trigger pathology in early age-related macular degeneration., PMID:31552301

Akt3-Mediated Protection Against Inflammatory Demyelinating Disease., PMID:31404142

Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab., PMID:30343280

AKT2 is the predominant AKT isoform expressed in human skeletal muscle., PMID:29595878

Electroacupuncture mitigates endothelial dysfunction via effects on the PI3K/Akt signalling pathway in high fat diet-induced insulin-resistant rats., PMID:29502072

Epithelial mesenchymal transition induced by the CXCL9/CXCR3 axis through AKT activation promotes invasion and metastasis in tongue squamous cell carcinoma., PMID:29286143

miR-608 regulates apoptosis in human lung adenocarcinoma via regulation of AKT2., PMID:29075783

TRAIL DR5-CTSB crosstalk participates in breast cancer autophagy initiated by SAHA., PMID:29018571

Immuno-Matrix-Assisted Laser Desorption/Ionization Assays for Quantifying AKT1 and AKT2 in Breast and Colorectal Cancer Cell Lines and Tumors., PMID:28853539

Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example., PMID:28802252

Human Plasma Thioredoxin-80 Increases With Age and in ApoE-/- Mice Induces Inflammation, Angiogenesis, and Atherosclerosis., PMID:28473446

AKT2 Regulates Pulmonary Inflammation and Fibrosis via Modulating Macrophage Activation., PMID:28455433

Autophagy confers resistance to lipopolysaccharide-induced mouse hepatocyte injury., PMID:27469366

Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment., PMID:27223437

Stability and function of adult vasculature is sustained by Akt/Jagged1 signalling axis in endothelium., PMID:26971877

The Effects of 52 Weeks of Soccer or Resistance Training on Body Composition and Muscle Function in +65-Year-Old Healthy Males--A Randomized Controlled Trial., PMID:26886262

ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis., PMID:26883061

Akt2 and p-Akt overexpression in oral cancer cells is due to a reduced rate of protein degradation., PMID:26393327

Did circulating tumor cells tell us all they could? The missed circulating tumor cell message in breast cancer., PMID:26349664

Mechanical stretch enhances the expression and activity of osteopontin and MMP-2 via the Akt1/AP-1 pathways in VSMC., PMID:25986148

Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation., PMID:25823994

Cep55 regulates embryonic growth and development by promoting Akt stability in zebrafish., PMID:25667221

Silencing of COX-2 by RNAi modulates epithelial-mesenchymal transition in breast cancer cells partially dependent on the PGE2 cascade., PMID:25520137

MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability., PMID:25428377

Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma., PMID:24895459

AKT/mTOR and c-Jun N-terminal kinase signaling pathways are required for chrysotile asbestos-induced autophagy., PMID:24735948

Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells., PMID:24550521

PI3K/PTEN/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel., PMID:24421178

Characterization of the Akt2 domain essential for binding nuclear p21cip1 to promote cell cycle arrest during myogenic differentiation., PMID:24194853

Identification and quantification of AKT isoforms and phosphoforms in breast cancer using a novel nanofluidic immunoassay., PMID:23929892

Datasheet

Document Download

Anti-AKT2 Antibody (R3J20).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-AKT2 Antibody (R3J20) [RHD96601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only